|
BIOENGINEERED BANDAGES
By Sean Henahan, Access Excellence
AKRON, OH--
New bioengineered bandages go beyond the barrier role
played by Band-Aids to provide immune stimulation and quicker
healing, report researchers from the University of Akron.
The Genetically Engineered Biological Bandage, or GEBB, is a
portable tissue-culture system, a "living bandage," which
consists of a polymer membrane in the shape of a bag or envelope
that will be placed on a wound. Inside the bag are normal human
skin cells like those currently used in the treatment of burns
and other chronic wounds. Using recombinant DNA techniques,
genetic engineers can obtain segments of DNA which are inserted
into the skin cells, causing them to release special proteins --
human growth factors.
These growth factors pass through the polymer membrane (designed
to be porous only to them) and into the wound, facilitating the
healing process. The ability of growth factors to participate in
the wound repair process has been known for some time, but it has
been difficult to keep them viable long enough for practical
application to wounds. The GEBB overcomes that dilemma, because
it provides a complete, living environment for the production of
human growth factors. The dressing lasts three to five days and
releases growth factors at a constant rate.
"These are third-generation wound dressings that work by
stimulating the body's immune system to trigger a faster response
toward repair. Patients benefit because it translates into
shorter hospital stays and faster recovery times after surgery,"
notes developer Daniel Smith, professor of chemistry and
biomedical engineering at the University of Akron.
"Essentially we've developed an excellent delivery system for
biological agents, "Smith explains. He envisions alternate
versions of the bandage used to treat acute acne or psoriasis.
And because the bandage is "clean," it significantly increases
the safety factor of handling biological elements.
The discovery could benefit as many as three million Americans
per year who suffer from wounds that under normal treatment don't
repair very well, such as severe burns, diabetic ulcers, or
bedsores.
Related information on the
Internet
Human Genome
Primer
|
|